Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Abstract The authors performed a retrospective and comparative study to compare the efficacy of intravitreal aflibercept and bevacizumab for patients with myopic choroidal neovascularization (mCNV). The patients with treatment-naïve mCNV received 1 + PRN intravitreal bevacizumab from March 2008 to F...
|Main Authors:||, , , , , , ,|
Nature Publishing Group